document with dr ranjan and accolades replaced picture.png

Charak Clinical Research Center has just completed an NIMH (National Institute of Mental Health) funded study that has led to groundbreaking research, soon to appear in an internationally recognized publication. Additionally, we will soon be starting another NIMH funded study at Charak.

Current Clinical Research Studies

Treatment Resistant Depression

A long term study of the safety & efficacy of VNS (Vagus Nerve Stimulation) as an adjunctive therapy to individuals diagnosed with Treatment Resistant Bipolar Depression compared to a

no-stimulation control group.

18+

Depression

ELIGIBILITY FORM

Adolescent Schizophrenia and Bipolar Depression

This is a two-month long study evaluating the efficacy and safety of Caplyta (lumateperone) as a monotherapy for the treatment of major depressive episodes in bipolar and schizophrenic pediatric patients.

13-17

Schizophrenia/ BPD

ELIGIBILITY FORM

Adolescent Bipolar Disorder

An open label, yearlong study in the safety and tolerability of flexible dosing of FANAPT (iloperidone) in adolescent patients.

13-17

Bipolar Disorder

ELIGIBILITY FORM

Adolescent Autism

A two-month-long study evaluating the safety and efficacy of Caplyta (lumateperone) in treating irritability in pediatric patients with autism as a monotherapy.